Opposing roles for AMPK in regulating distinct mitophagy pathways
Mitophagy degrades damaged mitochondria, but we show here that it can also target functional mitochondria. This latter scenario occurs during programmed mitophagy and involves the mitophagy receptors NIX and BNIP3. Although AMP-activated protein kinase (AMPK), the energy-sensing protein kinase, can influence damaged-induced mitophagy, its role in programmed mitophagy is unclear. We found that AMPK directly inhibits NIX-dependent mitophagy by triggering 14-3-3-mediated sequestration of ULK1, via ULK1 phosphorylation at two sites: Ser556 and an additional identified site, Ser694. By contrast, AMPK activation increases Parkin phosphorylation and enhances the rate of depolarization-induced mitophagy, independently of ULK1. We show that this happens both in cultured cells and tissues in vivo, using the mito-QC mouse model. Our work unveils a mechanism whereby AMPK activation downregulates mitophagy of functional mitochondria but enhances that of dysfunctional/damaged ones.
Authors
- Ian G. Ganley (ORCID: https://orcid.org/0000-0003-1481-9407)
- Kei Sakamoto (ORCID: https://orcid.org/0000-0001-8839-5980)
- Carol MacKintosh (ORCID: https://orcid.org/0000-0001-9166-589X)
- Aniketh Bishnu
- Lambert Montava‐Garriga (ORCID: https://orcid.org/0000-0003-0025-5700)
- Joyceline Cuenco (ORCID: https://orcid.org/0000-0002-7156-4976)
- Marianna Longo
- Pierpaolo Risiglione (ORCID: https://orcid.org/0000-0002-6832-3573)
Institutions
- University of Copenhagen (DK)
- University of Dundee (GB)
- Novo Nordisk Foundation (DK)
- MRC Protein Phosphorylation and Ubiquitylation Unit (GB)
Publication Details
- Journal
- Molecular Cell
- Published
- 2024-11-01
- DOI
- https://doi.org/10.1016/j.molcel.2024.10.025
- Citations
- 41
- Primary Topic
- Autophagy in Disease and Therapy
- Type
- article
- Field-Weighted Citation Impact
- 15.85
Funders
- European Commission
- Novo Nordisk
- Novo Nordisk Fonden
- Novo Nordisk Foundation Center for Basic Metabolic Research
- Centro de Investigação em Biomedicina
- Horizon 2020 Framework Programme
- Medical Research Council